|
|
|
IBC Life Sciences, Novotel London West
2006/03/14
-Understand what IT requirements are required to support current trends in R&D: An update on how informatics are enabling latest experimental methods in R&D Review latest advances and new approaches in modelling and stimulation: Get to grips with the impact of modelling and simulation across the R&D pipeline, understand where pharma are applying M&S to influence decisions and save time and money -Apply predictive technologies in R&D: Identify practical applications and future scope for predictive technologies in R&D -Exploit latest information presentation and retrieval strategies: Hear how leading organisations are tackling the challenge of uncovering key information from increasing data volumes -Discover latest tools and approaches for multi-source, multi format data management: Ensure your scientists have access to key information -Gain first hand insights from an international panel of leading academic and industry experts: Abbott GmbH, Amgen, AstraZeneca, Boehringer-Ingelheim Pharma, Cambridge Antibody Technology, Eli Lilly, F. Hoffmann-La Roche, Genzyme Europe, GlaxoSmithKline, Institute of Cancer Research, Johnson and Johnson, Novartis, Pfizer, Solvay Pharmaceuticals, University of Oxford, Windber Research Institute, Wyeth Research
|
|
|
|
|
|
Organized by:
|
|
IBC Life Sciences |
|
Invited Speakers:
|
|
-Jennifer Allerton, Chief Information Officer, F.Hoffman-La Roche, Switzerland -Jeremy Everett, Vice President, Discovery Chemistry Centres of Emphasis, Pfizer Global R&D, UK -Dr Jan Hoflack, Vice President of Medicinial Chemistry and ADME-Tox, Johnson & Johnson Pharmaceutical Research and Development, Belgium -Dr Jan Lundberg, Head of Global Discovery Research, AstraZeneca, Sweden -Dr Juergen Seega, Director R&D Information Systems, Abbott GmbH, Germany
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
Registration:
|
|
Contact Anthony Andrews for more information: anthony.andrews@informa.com
|
|
E-mail:
|
|
anthony.andrews@informa.com
|
|
|
|
|
|
|
|